Activity of Sulbactam-Durlobactam and Comparators Against a National Collection of Carbapenem-Resistant Acinetobacter baumannii Isolates From Greece
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Activity of Sulbactam-Durlobactam and Comparators Against a National Collection of Carbapenem-Resistant Acinetobacter baumannii Isolates From Greece
Authors
Keywords
-
Journal
Frontiers in Cellular and Infection Microbiology
Volume 11, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2022-01-20
DOI
10.3389/fcimb.2021.814530
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- In vitro activity of sulbactam-durlobactam against extensive-drug-resistant Acinetobacter baumannii isolates belonging to South America major clones
- (2021) Carolina S. Nodari et al. Journal of Global Antimicrobial Resistance
- Durlobactam, a New Diazabicyclooctane β-Lactamase Inhibitor for the Treatment of Acinetobacter Infections in Combination With Sulbactam
- (2021) Adam B. Shapiro et al. Frontiers in Microbiology
- In vitro activity of sulbactam-durlobactam against Acinetobacter baumannii-calcoaceticus complex isolates collected globally from 2016-2017
- (2020) Sarah M. McLeod et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- In vitro activity of sulbactam/durlobactam against clinical isolates of Acinetobacter baumannii collected in China
- (2020) Qiwen Yang et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- In vitro activity of sulbactam/durlobactam against global isolates of carbapenem-resistant Acinetobacter baumannii
- (2020) Harald Seifert et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- In vitro activity of the novel fluorocycline TP-6076 against carbapenem-resistant Acinetobacter baumannii
- (2019) Harald Seifert et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Global prevalence of colistin resistance in clinical isolates of Acinetobacter baumannii: A systematic review and meta-analysis
- (2019) Ali Pormohammad et al. MICROBIAL PATHOGENESIS
- Analysis of global prevalence of antibiotic resistance in Acinetobacter baumannii infections disclosed a faster increase in OECD countries
- (2018) Ruiqiang Xie et al. Emerging Microbes & Infections
- Predominance of international clone 2 OXA-23-producing- Acinetobacter baumannii clinical isolates in Greece, 2015: results of a nationwide study
- (2017) Spyros Pournaras et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Biology of Acinetobacter baumannii: Pathogenesis, Antibiotic Resistance Mechanisms, and Prospective Treatment Options
- (2017) Chang-Ro Lee et al. Frontiers in Cellular and Infection Microbiology
- ETX2514 is a broad-spectrum β-lactamase inhibitor for the treatment of drug-resistant Gram-negative bacteria including Acinetobacter baumannii
- (2017) Thomas F. Durand-Réville et al. Nature Microbiology
- Clinical and Pathophysiological Overview of Acinetobacter Infections: a Century of Challenges
- (2016) Darren Wong et al. CLINICAL MICROBIOLOGY REVIEWS
- Molecular Mechanisms of Sulbactam Antibacterial Activity and Resistance Determinants in Acinetobacter baumannii
- (2015) William F. Penwell et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Structural Basis for Carbapenem-Hydrolyzing Mechanisms of Carbapenemases Conferring Antibiotic Resistance
- (2015) Jeong Jeon et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Treatment Options for Carbapenem-Resistant and Extensively Drug-Resistant Acinetobacter baumannii Infections
- (2014) J. Alexander Viehman et al. DRUGS
- Single-Locus-Sequence-Based Typing of blaOXA-51-like Genes for Rapid Assignment of Acinetobacter baumannii Clinical Isolates to International Clonal Lineages
- (2014) S. Pournaras et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Carbapenem resistance and mortality in patients with Acinetobacter baumannii infection: systematic review and meta-analysis
- (2013) E.V. Lemos et al. CLINICAL MICROBIOLOGY AND INFECTION
- Early Insights into the Interactions of Different β-Lactam Antibiotics and β-Lactamase Inhibitors against Soluble Forms of Acinetobacter baumannii PBP1a and Acinetobacter sp. PBP3
- (2012) Krisztina M. Papp-Wallace et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Molecular epidemiology of Acinetobacter baumannii and Acinetobacter nosocomialis in Germany over a 5-year period (2005–2009)
- (2012) X. Schleicher et al. CLINICAL MICROBIOLOGY AND INFECTION
- Evolution of multidrug-resistant Acinetobacter baumannii clonal lineages: a 10 year study in Greece (2000-09)
- (2011) V. Gogou et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Changing carbapenemase gene pattern in an epidemic multidrug-resistant Acinetobacter baumannii lineage causing multiple outbreaks in central Italy
- (2010) Silvia D'Arezzo et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Molecular Epidemiology of Multidrug-Resistant Acinetobacter baumannii in a Tertiary Care Hospital in Naples, Italy, Shows the Emergence of a Novel Epidemic Clone
- (2010) M. Giannouli et al. JOURNAL OF CLINICAL MICROBIOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started